| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/06/2003 | EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof |
| 08/06/2003 | CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3 |
| 08/06/2003 | CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them |
| 08/06/2003 | CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434707A Method and compositions for preventing hormone induced adverse effects |
| 08/06/2003 | CN1434691A Tissue sensitizing compounds for females and methods and apparatus for the delivery of these compounds |
| 08/06/2003 | CN1433809A Medicine for treating gynecopathy and preparation process thereof |
| 08/06/2003 | CN1117092C Azadicyclic compound, its medicinal composition and medicinal use |
| 08/06/2003 | CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 08/06/2003 | CN1116888C Medicine composition for treating woman's sexual function disease |
| 08/06/2003 | CN1116877C Carboprost methylate preparation able to be absorbed via oral musoca and its preparing process |
| 08/05/2003 | US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 08/05/2003 | US6602903 Substituted heterocyclic compounds |
| 08/05/2003 | US6602888 Use of α1C specific compounds to treat benign prostatic hyperplasia |
| 08/05/2003 | US6602876 Adhesion receptor antagonists |
| 08/05/2003 | US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated |
| 08/05/2003 | US6602867 Triazole compounds with dopamine-D3-receptor affinity |
| 08/05/2003 | US6602863 Irreversible inhibitors of tyrosine kinases |
| 08/05/2003 | US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage |
| 08/05/2003 | CA2362917C Methods for anti-tumor therapy |
| 08/05/2003 | CA2115943C Novel process for the preparation of cetrorelix lyophilisate |
| 08/05/2003 | CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 07/31/2003 | WO2003062832A1 Fertility screening method and kit |
| 07/31/2003 | WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062245A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 07/31/2003 | WO2003062227A1 Rho-kinase inhibitors |
| 07/31/2003 | WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin |
| 07/31/2003 | WO2003062205A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders |
| 07/31/2003 | WO2003062203A1 Method |
| 07/31/2003 | WO2003061687A1 High-concentration preparation of soluble thrombomodulin |
| 07/31/2003 | WO2003061665A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 07/31/2003 | WO2003061660A1 Melanocortin receptor agonists |
| 07/31/2003 | WO2003061655A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 07/31/2003 | WO2003061634A1 Sustained release pharmaceutical composition |
| 07/31/2003 | WO2003061362A2 Methods and compositions for treating polycystic ovary syndrome |
| 07/31/2003 | WO2003020702A9 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 07/31/2003 | WO2003018545B1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3? |
| 07/31/2003 | WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 07/31/2003 | WO2002062762A3 Potassium channel openers |
| 07/31/2003 | WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | US20030144347 Method for treating autoimmune disease |
| 07/31/2003 | US20030144313 Non-steroidal, tetracylic compounds for estrogen-related treatments |
| 07/31/2003 | US20030144302 Process for making substituted pyrazoles |
| 07/31/2003 | US20030144291 Substituted indan derivatives |
| 07/31/2003 | US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 07/31/2003 | US20030144280 Heterocyclic imines, used as cyclooxygenase inhibitors, administered as inflammatory and pain relievers in disorders such as arthritis, neurodegeneration or cancer in mammals |
| 07/31/2003 | US20030144279 5-Heterocyclo-pyrazoles |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144268 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/31/2003 | US20030144259 Exemestane for use in the first-line treatment of metastatic, advanced hormone-dependent breast cancer, particularly in post-menopausal woman; endorcine therapy |
| 07/31/2003 | US20030144256 Administration of a retinoid or retinoid derivative that is able to act as an antagonist or inverse agonist of a retinoic acid receptor (RAR) for preventing spermatogenesis in a male mammal |
| 07/31/2003 | US20030144203 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/31/2003 | US20030143676 Receptor polypeptides and polynucleotides encoding such polypeptides; for treating a disorder characterized by an elevated level of osteopontin |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143278 Vaginal delivery of drugs |
| 07/31/2003 | US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection |
| 07/31/2003 | US20030143260 Administering to the cow salt of ester of methionine, an ester of methionine amide, and an ester of the hydroxy analogue of methionine |
| 07/31/2003 | CA2474292A1 Sustained release pharmaceutical composition |
| 07/31/2003 | CA2473927A1 Methods and compositions for treating polycystic ovary syndrome |
| 07/31/2003 | CA2473796A1 Substituted quinazolin-4-ylamine analogues |
| 07/31/2003 | CA2473781A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | CA2473510A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | CA2473386A1 Method |
| 07/31/2003 | CA2473036A1 Melanocortin receptor agonists |
| 07/31/2003 | CA2472835A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | CA2472240A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 07/31/2003 | CA2471989A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 07/31/2003 | CA2471342A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/30/2003 | EP1330469A2 Glycoproteins and methods of use therefof |
| 07/30/2003 | EP1330455A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 07/30/2003 | EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 07/30/2003 | EP1330451A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/30/2003 | EP1330439A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 07/30/2003 | EP1330430A2 Integrin receptor inhibitors |
| 07/30/2003 | EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 07/30/2003 | EP1330257A1 Gnrh analogues for treatment of urinary incontinence |
| 07/30/2003 | EP1330255A2 Use of a preparation of cimicifuga racemosa |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | EP1330238A1 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| 07/30/2003 | EP1233763B1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 07/30/2003 | EP1082962B1 Utilization of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factors nf-(k)b |
| 07/30/2003 | EP1075256B1 Arylhydrocarbon receptor ligand antagonists |
| 07/30/2003 | EP0902022B1 Novel benzofuranone derivatives and process for producing the same |
| 07/30/2003 | CN2562769Y Shanjia paste for curing hyperplasia of mammary glands and mastadenitis |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433426A 16,17-carbocyclic condensed steroid compounds having seletive estrogenic activeity |